Introduction 48 49
Renal dysfunction leads to accumulation of uremic toxins in patients with chronic 50 kidney disease (CKD) . Approximately 90 compounds have been reported as uremic 51 toxins or their candidates (7, 27) . Indoxyl sulfate (IS) is a representative protein-bound 52 uremic toxin that plays a role in the progression of CKD (28). Previous studies have 53
proposed that IS exhibits renal toxicity mainly by inducing oxidative stress on proximal 54 tubular cells (23, 24) . In addition, IS induces oxidative stress on vascular smooth 55 muscle cells and endothelial cells (14, 26, 34) . Therefore, IS is also considered to be 56 involved in the progression of cardiovascular disease associated with CKD (2, 15) . 57
Recently, IS has been reported to be an endogenous ligand for the aryl 58 hydrocarbon receptor (AhR), also called the dioxin receptor (29) . The AhR is a 59 ligand-activated transcription factor and normally exists in the cytosol in an inactive 60 form. Upon binding ligands such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), this 61 receptor translocates into the nucleus, dimerizes with the AhR nuclear translocator 62 (ARNT), and induces the expression of several genes including cytochrome P450 1A1 63
Measurement of plasma EPO and IS concentration 117
Plasma EPO concentrations were measured using a Mouse/Rat EPO 118 Serum/Plasma kit (MA6000; Meso Scale Discovery, Rockville, MD) according to the 119 manufacturer's instructions. Plasma IS concentrations were measured by liquid 120 chromatography/electrospray ionization-tandem mass spectrometry (API 4000 121 LC/MS/MS System; Takara Bio, Shiga, Japan) as described by Kikuchi et al (19) . 122 123 Cell culture, induction of hypoxic response and IS treatment 124
The human hepatoma cell line HepG2 was purchased from DS Pharma 125
Biomedical (Osaka, Japan). The cell line retains the ability to express EPO in response 126 to hypoxic culture or treatment with hypoxia mimicking agents such as cobalt chloride 127 (11). The culture medium was MEM (Sigma-Aldrich, St. Louis, MO) supplemented 128 with 10% heat-inactivated fetal bovine serum (HyClone Laboratories, Logan, UT), 1% 129 non-essential amino acid solution (Sigma-Aldrich), 100 U/mL penicillin and 100 µg/mL 130 streptomycin (Life Technologies, Tokyo, Japan), except in transfection experiments in 131 which antibiotics-free medium was used. Cells were cultured at 37°C in a 5% CO 2 132 humidified incubator unless otherwise indicated. For induction of cellular hypoxic 133 response, cells were treated with 50 μM cobalt chloride (Wako Pure Chemical 134 Industries). Alternatively, cells were cultured under hypoxic condition using an 135 AnaeroPack System (Mitsubishi Gas Chemical, Tokyo, Japan) to deplete the oxygen 136 concentration to < 1% in 1 hour and providing a 5% CO 2 atmosphere without changing 137 medium pH (18, 31), for periods indicated in the figure legends. IS (Alfa Aesar, Ward 138 Hill, MA) was added 1 hour prior to cobalt chloride treatment or immediately before 139 hypoxic culture. In some experiments, the potent AhR agonist TCDD (dissolved in 140 8 DMSO; Cambridge Isotope Laboratories, Tewksbury, MA) was added instead of IS. 141
The final concentration of DMSO in the medium was less than 0.2% in all experiments. 142 143
Cell viability assay 144
HepG2 cells (1×10 4 /well) were seeded into 96-well plates and cultured overnight. 145
After treatment with IS (0, 500, 1500 or 5000 μM) in the presence or absence of cobalt 146 chloride for 24 hours, 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium 147 bromide (MTT; Dojindo Laboratories, Kumamoto, Japan) was added and cells were 148 further cultured for 1 hour. The formazan crystals were then dissolved in DMSO and 149 absorbance at 570 nm was determined. 150
151

RNA isolation from cells and tissues and quantitative real-time PCR 152
HepG2 cells (2.5×10 5 /well) were seeded into 12-well plates and cultured 153 overnight. The growth medium was replaced with the medium containing 0.1% fetal 154 bovine serum and cells were further cultured overnight under serum starvation. Then, 155 cells were treated with IS and cultured with cobalt chloride or under hypoxic condition 156 as described above. In some experiments, the AhR antagonist CH-223191 157 (Sigma-Aldrich) dissolved in DMSO was added at the same time of IS treatment. Total 158 RNA was extracted from cultured cells or the liver and renal cortex tissues of rats using 159 an Illustra RNA Spin mini kit (GE Healthcare, Tokyo, Japan) according to the 160 manufacturer's instructions. Total RNA (250 ng for cells and 500 ng for tissues in 10 μL 161 reaction volume) was reverse transcribed with random hexamer primers using a 162
PrimeScript RT master mix (Takara Bio). Real-time RT-PCR was then performed with 163 fivefold-diluted cDNA using a KAPA SYBR fast qPCR kit (Nippon Genetics, Tokyo,9 Japan) and gene specific primer pairs (35-40 cycles at 95 ºC for 3 sec, 60 ºC for 30 sec). 165
Values for the mRNA were normalized to HPRT mRNA expression for human genes 166 and GAPDH mRNA expression for rat genes. Analyses were conducted with a Thermal 167
Cycler Dice Real Time System (Takara Bio). The sequences of primers used are listed in 168 
Nuclear protein extraction and immunoprecipitation 194
HepG2 cells (7.5×10 6 /dish) were seeded into 10-cm dishes and cultured overnight. In the absence of hypoxic stimulation, IS up to 1500 µM had no effect on EPO 234 mRNA expression ( Figure 1A ). Under hypoxic culture conditions (O 2 < 1%), EPO 235 mRNA expression was elevated significantly by 2.8-fold and this elevation was 236 significantly suppressed by IS at 100 µM or higher ( Figure 1B A single oral dose of indole at 100 mg/kg to rats caused marked increases in 244 plasma IS concentration (5 ± 1 μM in vehicle-treated rats; 127 ± 23, 52 ± 19 and 29 ± 9 245 μM at 3, 6 and 9 hours, respectively, after administration in indole-treated rats). 246
In the bleeding experiments in which 1 mL of blood per 100 g body weight was 247 drawn from each rat, mean plasma IS concentration was elevated to 140 µM by a single 248 oral dose of indole at 100 mg/kg, whereas IS concentration was less than 10 µM 249 throughout the experiment in the vehicle group (Figure 2A ). Plasma EPO concentration 250 increased gradually over time after blood withdrawal in the vehicle group, but the 251 13 increase was significantly suppressed by administration of indole ( Figure 2B ). Blood 252 withdrawal also induced EPO mRNA expression in the renal cortex but not in the liver, 253 and the induction was significantly suppressed by administration of indole ( Figure 2C) . 254
255
IS suppresses hypoxia-induced transcriptional activation of HIF in HepG2 cells 256
Transcriptional activity of HIF was assayed by measuring HRE-luciferase activity 257 in HepG2 cells. In the absence of hypoxic stimulation, IS even at 500 µM had no effect 258 on HRE-luciferase activity ( Figure 3A ). Hypoxic stimulation (O 2 < 1%) increased 259 HRE-luciferase activity significantly by 6.50-fold and this increase was significantly 260
suppressed by IS at 100 µM or higher ( Figure 3B ). Furthermore, in the case of cobalt 261 chloride treatment, the 5.24-fold increase in HRE-luciferase activity was significantly 262
suppressed by IS at 20 µM or higher ( Figure 3C ). Since transcriptional activation of HIF 263 is induced by nuclear accumulation of HIF-α subunits, the amounts of HIF-1α and 264 HIF-2α in nuclear extracts were measured. Cobalt chloride treatment increased nuclear 265 accumulation of both HIF-1α and HIF-2α, and this increase was suppressed by IS 266 ( Figure 3D) . 267
To examine the possibility that the suppression by IS is due to inhibition of 268 endogenous expression of HIFα subunits, the effect of IS on mRNA expression of HIFα 269 subunits was examined. IS up to 500 µM had no effect on HIF2α mRNA expression in 270 the presence and absence of cobalt chloride (data not shown). IS also had no effect on 271 In the absence of hypoxic stimulation, HRE-luciferase activity was not affected by 280 treatment with IS, an AhR antagonist CH-223191, or both ( Figure 4A ). The increase in 281 HRE-luciferase activity induced by hypoxic culture (O 2 < 1%) was significantly 282 suppressed by IS (100 µM), and IS-induced suppression was completely abolished by 283 co-treatment with CH-223191 (1 µM), whereas CH-223191 alone had no influence on 284 hypoxia-induced HIF activation ( Figure 4B) . Similarly, the increase in HRE-luciferase 285 activity induced by cobalt chloride was significantly suppressed by IS (100 µM) and 286
IS-induced suppression was abolished by co-treatment with CH-223191 in a 287
concentration-dependent manner ( Figure 4C) . 288
In the experiments using siRNA, transfection of AhR-siRNA inhibited cellular 289 expression of AhR protein, while transfection of non-targeting siRNA had no effect 290 ( Figure 4D ). Cobalt chloride induced significant increases in HRE-luciferase activity in 291 all cells, and this increase was suppressed by IS (100 µM) in non-targeting 292 siRNA-transfected cells but not in AhR-siRNA-transfected cells ( Figure 4E ). Hence, 293
AhR-siRNA transfection abolished the suppression of cobalt chloride-induced HIF 294 activation by IS. 295
Since the HRE-luciferase assay measures HIF activation but not EPO expression, 296 the effect of AhR inactivation on the suppression of EPO mRNA expression by IS was 297 further examined. The elevation in EPO mRNA expression induced by hypoxic culture 298 (O 2 < 1%) was significantly suppressed by IS (500 µM), and the suppression was 299 15 abolished by co-treatment with CH-223191 (1 µM), while CH-223191 alone had no 300 effect on hypoxia-induced EPO mRNA expression ( Figure 4F) . 301
302
TCDD also suppresses hypoxia-induced transcriptional activation of HIF in 303
HepG2 cells 304
Treatment with TCDD and/or CH-223191 had no effect on HRE-luciferase 305 activity ( Figure 5, left panel) . In contrast, cobalt chloride-induced increase in 306 HRE-luciferase activity was significantly suppressed by treatment with TCDD (10 nM) 307 and this suppression was completely abolished by co-treatment with CH-223191 308 ( Figure 5 , right panel). Furthermore, nuclear accumulation of HIF-1α and HIF-2α was 309 suppressed by TCDD as well as by IS ( Figure 3D) . 310
311
IS induces activation of AhR in both HepG2 cells and rats 312
In HepG2 cells, IS significantly induced the expression of CYP1A1 mRNA, one 313 of the major genes regulated by AhR, by 50-fold even at 100 µM ( Figure 6A ). 314
Furthermore, IS increased the amount of AhR in nuclear protein extract in a 315 concentration-dependent manner ( Figure 6B) . 316
In rats, administration of indole that caused marked increases in plasma IS 317 concentration (as described above) induced significant CYP1A1 mRNA expression in 318 both the liver and renal cortex tissues compared with vehicle-treated rats; particularly in 319 the renal cortex tissue, the increase was 726-fold at 3 hours after indole administration, 320 and was still 16-fold at 9 hours although there was no significant difference ( Figure 7A) . 321
In the liver, the amount of AhR in nuclear protein extract increased significantly by 322 administration of indole ( Figure 7B and subsequent EPO production. In the present study, we investigated the detailed 345 mechanism of the suppressive effect of IS using EPO-producing HepG2 cells and rats. 346
First, we investigated whether IS at clinically relevant concentrations (109 ± 61 347 μM) in CKD patients reported previously (7) suppressed hypoxia-induced HIF 348 activation and subsequent EPO production in vitro. We found that hypoxia-or cobalt 349 chloride-induced EPO mRNA expression was suppressed by IS at 100 μM or higher in 350 suggests that p-cresyl sulfate may contribute to renal anemia (33). Although further 420 studies to elucidate the molecular mechanism of the effect of these uremic toxins are 421 needed, both IS and these uremic toxins could be involved in the progression of renal 422
anemia. 423
Collectively, the results of this study demonstrate that IS at concentrations similar 424 to the blood IS levels in CKD patients suppresses HIF-dependent EPO production both 425 in vitro and in vivo. Although further investigations in CKD model animals and patients 426 are required, our data suggest that IS contributes to the progression of renal anemia in 427 CKD patients whose blood IS levels are elevated due to renal dysfunction. Furthermore, 428 this study is the first to elucidate the detailed mechanism by which the activation of 429 
